Liquid Prami (pramipexole) has demonstrated properties and actions similar to that of cabergoline in clinical research. Based on supporting research, pramipexole acts as a dopamine agonist. Dopamine’s main function as a hormone is to inhibit the release of prolactin from the anterior lobe of the pituitary. Thus, pramipoxole can play an important role in the inhibition of prolactin secretion.
Pramipexole is a dopamine agonist with inhibiting effects on prolactin release from the pituitary. This has allowed research into and shown positive effects with; Depression, Bipolar disorder, Gyno (Gynecomastia), Fibromyalgia, Cluster headaches, Sexual dysfunction, Parkinson’s disease, Restless legs syndrome and the lowering of prolactin levels. Prami has shown very promising in treating many conditions from mental to hormonal and even physical, it truly is a great compound with many possibilities. It has shown extremely effective at lowering prolactin levels in various studies. This is of great interest because abnormally high levels of prolactin can cause unwanted effects, mainly an issue found in males with abnormal hormone levels. This may include symptoms such as lactation and Gyno (development of female like breast tissue). Pramipexole has a half-life between 8-10 hours.